A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 25
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SD
Long Form : disease stabilization
No. Year Title Co-occurring Abbreviation
2018 A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. ACC, MTD, PR
2018 Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours. HER2, PK
2015 Photodynamic therapy in palliative treatment of head and neck cancer. PDT, PR
2015 Predictive biomarkers to chemotherapy in patients with advanced melanoma receiving the combination of cisplatin--vinblastine--temozolomide (PVT) as first-line treatment: a study of the Hellenic Cooperative Oncology Group (HECOG). CI, ERCC1, HeCOG, MGMT, MM, ORR, PVT, TMZ, WT
2015 Sequence of treatment in locally advanced and metastatic renal cell carcinoma. IFN-alpha, OS, PFS, RCC
2015 Topotecan plus cyclophosphamide in adults with relapsed or refractory pediatric-type sarcoma: a retrospective analysis from the German Sarcoma Medical Oncology Group (AIO). AIO, PD, TC
2014 Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma. ASCT, HL, PR, RIT
2013 A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer. AGC, CR, ORR, OS, PD, PFS, PR
2011 Advanced aggressive fibromatosis: Effective palliation with chemotherapy. AF, MTX/VBL, PD, PLD, PR
10  2009 Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). GBM, GICNO, PFS-6, PR
11  2008 Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience. CBR, CR, OS, PR, RR, STS, TTP
12  2008 Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. CRC, PR, PS
13  2008 Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial. DC
14  2005 Clinical benefit in NSCLC: advanced-stage patients require symptom-improving palliation. Experiences from the 'Iressa' expanded access program. EGFR, NSCLC
15  2005 Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer. APTT, DLT, ECOG, HGF, i.v, PR, VEGF
16  2004 A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen. SERM
17  2004 Combined topoisomerase I inhibition for the treatment of metastatic colon cancer. MTD
18  2004 Endovascular interventions in advanced cancer of the uterus. CAP, CR, IIA, PD, PR
19  2002 [Clinical trial of lentaron for postmenopausal patients with advanced breast cancer]. CR, PD, PR
20  2000 High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment. CI, CR, PR, TTF, TTP
21  1999 Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients. OC, PD, PR, SCLC
22  1998 13-cis retinoic acid and interferon alfa-2a in the treatment of metastatic renal cell carcinoma. CRA, IFN 2a, PR
23  1997 Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival. BC, MET, OS, PR
24  1996 Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD study. 5-FU, ACC, LV, MTX, PR
25  1992 Phase II study of epirubicin sequential methotrexate and 5-fluorouracil for advanced colorectal cancer. CR, PD, PR